Healthcare Trending Market Reports

  GE Healthcare (U.S.), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), Toshiba Medical Systems Corporation (Japan) are some of the prominent players at the forefront of competition in the Global Cardiovascular Ultrasound Market and are profiled in MRFR Analysis.  Global Cardiovascular Ultrasound  Market - Overview Cardiovascular ultrasound imaging system market has increased due to increase in the incidence of cardiovascular diseases, changing lifestyle of people, increase in incidence of diabetes and other risk factors favouring the growth of this market. Increase in demand of cardiovascular ultrasound imaging system in hospitals for diagnosis of heart disease or before any surgical procedure favour the growth of this market.     Cardiovascular diseases gain a huge attention due to increasing prevalence. Due to increasing number of death from cardiovascular diseases, number of companies are in a race for the introduction of th

  Market Scenario The Global Medical Digital Imaging Devices Market is expected to grow significantly over the forecast period. The market held a market value of USD 12.9 billion in 2017 and is projected to register a CAGR of 7.1% over the forecast period. Medical digital imaging devices are devices used to image the body to obtain a correct diagnosis and determine future care. The growing demand for medical digital imaging devices is due to factors such as increasing incidence and prevalence of chronic diseases across the globe, technological advancements in the imaging systems, growing government investments for modernization of imaging facilities, and the rising number of diagnostic imaging centers are driving the market growth of diagnostic imaging. However, the high cost of diagnostic imaging systems, technological limitations associated with standalone systems, and unfavorable healthcare reforms in the US are the key factors limiting the growth of the market.     Top Company Prof

    Market Scenario The global urinary catheters market is expected to grow significantly over the forecast period. The market held a market value of USD 1,603 million in 2017 and is projected to grow at a CAGR of 7.8% over the forecast period. Numerous factors such as increasing prevalence of various urologic diseases, increasing cases of hospitalization, increasing long term use of urinary catheters by the aged population for the growth of the market during the forecast period. Moreover, rising incidents of kidney and other renal diseases offer a lot of benefits which positively affects the market growth. According to the National Kidney Foundation, one in five women may suffer from urinary tract infections at list once in a lifetime. In 2015, it was estimated that 150 million urinary tract infection occurs yearly on a global basis. Prevalence of urinary tract diseases is more in females than males, 40% to 50% of whom will suffer at least one clinical episode during their lifetime. B

  Market Scenario The global electronic skin patches market is projected to grow significantly over the forecast period. It is estimated that the global electronic skin patches market is expected to register a CAGR of 18.3% during the forecast period of 2018–2023. The increasing demand for electronic skin solutions in the wearable electronics sector and technological advancement is expected to drive the growth of the market. Factors such as the high cost of electronic skin patches are limiting the growth of the market. Moreover, major companies in the market are involved in investing more in research and development and new product launches to strengthen their position in the market. For instance, in March 2017, 3M developed adhesives to improve wearable medical devices GET FREE SAMPLE @  https://www.marketresearchfuture.com/sample_request/7568 Segmentational Analysis: On a regional basis, the electronic skin patches market in the Americas is predicted to dominate the market during the

  Market Highlights The global solid phase extraction industry market is expected to register a CAGR of 4.62% to reach USD 474.73 million till 2023. Solid phase extraction (SPE) is a sample preparation process by which compounds that are dissolved or suspended in a liquid mixture are separated from other compounds in the mixture according to their physical and chemical properties.   Technological advancements in instrumentation, rising government investments in academics and life sciences, and high growth in the generic pharmaceutical market and contract research organizations (CRO are responsible for the growth of the global solid phase extraction industry market in the recent years. However, costs related to instruments and unfavorable government policies and regulations are likely to restrain the market growth over the forecast period. ALSO READ @  https://www.medgadget.com/2020/06/solid-phase-extraction-market-to-register-cagr-of-4-62-by-2023-global-industry-growth-size-estimation-

  Market Highlights:   The Global Hemorrhoids Treatment Market is expected to grow at an approximate CAGR of 7.1% during forecast period, 2018–2023. Factors such as growing demand for treatment; increasing prevalence of lifestyle diseases, increase in number of surgeries which may require these treatments for postoperative care; and increase in demand to reduce complications & infections relating to hemorrhoids are expected to drive the market. Growing aging population contributes to increased need of hemorrhoids treatment. There are two types of hemorrhoids (piles), internal and external, which vary in their location. While there is no specific cause ofhemorrhoids, there are a number of causes that may lead to the disorder: age, chronic constipation or diarrhea, pregnancy, heredity, discomfort during bowel movements, impaired bowel function. Some patients do not even experience symptoms, but those that do experience bleeding during bowel movements, protrusion during bowel movement

  Market Highlights The global liquid handling system market is anticipated to hold a market value of USD 2.95 billion in the year 2017 and is expected to grow at a CAGR of 8.7% during the forecast period. Liquid handling system is generally used in the pharmaceutical, life science, or biochemical laboratories. The liquid handling system can perform simple, monotonous routine tasks as well as complex pipetting task efficiently. Market Scenario Global liquid handling system market is expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 2.95 billion in 2017 and is projected to grow at a CAGR of 8.7% over the forecast period. The liquid handling system is a laboratory instrument system consisting of tools and equipment designed to execute mixing, sampling, and combining of liquid samples. The factors such as an increase in investments in drug development, growing demand for high-output screening, growing expenditure on resea

    Market Highlights Diabetes drugs are the drugs which are administered for the treatment of different types of Diabetes.   The prevalence of diabetes is on the rise due to increased life expectancy, changing lifestyles, and the rising incidence of obesity. Diabetes can be kept in control with the help of medication, exercise and controlled diet.  BRICS Diabetes treatment and prevention market is expected to reach  USD 9.45 billion by 2023 at a CAGR of 11.52%  during forecast period 2017 to 2023. ALSO READ @  https://www.medgadget.com/2019/06/diabetes-treatment-and-prevention-market-growing-in-brics-2019-global-industry-by-type-size-2023-technology-trends-insights-analysis-and-demand-estimated-by-players-at-a-cagr-of-11-52.html BRICS Diabetes treatment and prevention market is expected to reach USD 9.45 billion by 2023 at a CAGR of 11.52% during forecast period 2017 to 2023. Test the market data and market information presented through more than 45 market data tables and figures spre

    Segmentation The global tenecteplase drug market is segmented on the basis of application, dosage and end users. The tenecteplase drug market, by application segmented into myocardial infarction, stroke, deep vein thrombosis. The tenecteplase drug market, by dosage intravenous dosage and intracatheter instillation dosage. Intravenous dosage is sub-segmented into adult and geriatric and intracatheter instillation dosage is sub-segmented into adult, children, and adolescents weighing 30 kg, infants. On the bases of end-user, it is segmented into hospitals and clinics, surgical centers, research centers and other. Also read @  https://www.medgadget.com/2019/06/tenecteplase-market-to-experience-a-substantial-cagr-during-the-forecast-period-2018-to-2023-by-genentec-inc-gennova-pharmaceutical-merck-ltd-hisun-usa-etc.html  Further, the report presented statistics like- Coronary heart disease (CHD) (43.8%) is the major cause of deaths attributable to cardiovascular disease (CVD) in the US,

    Market Research Future (MRFR) claimed that a lot of factors play in favor of this market. For instance, people becoming aware of various procedures, lowering of procedural cost, less time-consuming methods, better technological support, and other factors are expected to take the global market for dental 3D printing market ahead. However, stringent regulatory implementations can prohibit the natural growth rate of the market. Also Read :   https://www.medgadget.com/2019/11/dental-3d-printing-market-expected-to-mark-24-5-during-2019-to-2023-global-analysis-by-top-competitors-industry-share-size-growth-status-and-opportunities.html Competitive Analysis A number of market players are expected to promote significant strategic moves in the coming years to ensure that the global market for dental 3D printing grows properly. On the other hand, these moves solidify their personal claims in the market. MRFR made a detailed survey of a few companies to understand the reasons behind their move

      Market Scenario   The global arthroscopy instruments market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global arthroscopy instruments market is expected to register a CAGR ~6.5 % during the forecast period of 2018–2023.   A number of factors such as the increasing preference for minimally invasive procedures, ongoing technological advancements, and improving regulatory framework are fueling the growth of the global arthroscopy instrument market. Additionally, increasing incidence of sports-related musculoskeletal disorders, such as the bone tumor, rheumatoid arthritis, and osteoarthritis, are propelling the growth of this market. The world health organization predicts the prevalence of rheumatoid arthritis to be between 0.3% and 1% and more common in women and developed countries. Moreover, the prediction also states that 9.6% of men and 18.0% of women aged over 60 years have osteoarthritis.   also read @  https://www.marketwatch